These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 3076114)

  • 1. The future of pharmacological therapy for risk factor reduction. Hypertension.
    Hansson L
    Drugs; 1988; 36 Suppl 3():110-4. PubMed ID: 3076114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of doxazosin therapy on risk of coronary heart disease.
    Hansson L
    Am Heart J; 1988 Dec; 116(6 Pt 2):1832-7. PubMed ID: 2904759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension--when is the clinical problem solved? When patients are rendered normotensive.
    Mancia G; Lanfranchi A; Cattaneo BM; Grassi G
    Cardiology; 1994; 85 Suppl 1():58-64. PubMed ID: 7743536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What are we really achieving with long-term drug therapy?
    Hansson L
    Am J Hypertens; 1988 Oct; 1(4 Pt 1):414-20. PubMed ID: 3063292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current and future strategies in the treatment of hypertension.
    Hansson L
    Am J Cardiol; 1988 Feb; 61(5):2C-7C. PubMed ID: 3341223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of plasma lipidomics in studying the response of patients with essential hypertension to antihypertensive drug therapy.
    Hu C; Kong H; Qu F; Li Y; Yu Z; Gao P; Peng S; Xu G
    Mol Biosyst; 2011 Dec; 7(12):3271-9. PubMed ID: 22009255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of antihypertensive drugs on the cardiovascular patient.
    Hansson L
    Am Heart J; 1987 Jul; 114(1 Pt 2):221-3. PubMed ID: 3300234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is hypertension treated adequately?
    Hansson L; Robertson JI
    Drugs; 1987; 34 Suppl 3():1-6. PubMed ID: 3443056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins in hypertension: are they a new class of antihypertensive agents?
    Feldstein CA
    Am J Ther; 2010; 17(3):255-62. PubMed ID: 19918164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risk factors and their interactions in hypertensives.
    Lindholm LH
    J Hypertens Suppl; 1991 Dec; 9(3):S3-6. PubMed ID: 1797997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive agents and cardiovascular risk factors.
    Fodor JG
    Clin Ther; 1986; 8(5):490-509. PubMed ID: 2876774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicted reductions in the risk of coronary heart disease by antihypertensive therapy: the confounding effect of lipids.
    Hansson L
    J Hypertens Suppl; 1990 Mar; 8(1):S13-6. PubMed ID: 2185349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The case for a greater blood pressure fall.
    Hansson L
    Clin Exp Hypertens; 1996; 18(3-4):425-34. PubMed ID: 8743032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experiences from hypertension trials. Impact of other risk factors.
    Samuelsson O
    Drugs; 1988; 36 Suppl 3():9-20. PubMed ID: 3076127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension as a risk factor for cardiac events--epidemiologic results of long-term studies.
    Kannel WB
    J Cardiovasc Pharmacol; 1993; 21 Suppl 2():S27-37. PubMed ID: 7692148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive therapy: new strategies beyond blood pressure control.
    Stumpe KO
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S1-4. PubMed ID: 1283182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modification of cardiovascular risk factors during antihypertensive treatment: current and new approach trends. The urapidil experience.
    Leonetti G
    Blood Press Suppl; 1994; 4():49-52. PubMed ID: 7804513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.